Clinical and experimental studies of the effectiveness of vascular peptides

Cardiovascular diseases are among the foremost causes of death and disability globally. To combat these maladies, scientific and research communities have undertaken various approaches and methodologies, including the investigation of vascular peptides.

In a recently conducted scientific study within the framework of the SIC project "Clinical and experimental studies of the efficacy of vascular peptides", an in-depth review of the primary aspects of the aforementioned topic will be conducted. The aspects addressed include:

• clinical application of vascular peptides
• efficacy of these peptides
• their potential for development in the fields of medicine and pharmacology

The new study is presented in a convenient presentation format with the use of visual methods of data visualization — graphs and other illustrative materials — to make the information more accessible and visually appealing:

• focuses on cardiovascular diseases and polypeptide complexes, including Ventfort and Vesugen vasoprotective tripeptide.
• examines the efficacy of Vesugen in chronic arterial insufficiency and its effect on cerebral blood vessels
• presents in vitro studies of the drug Ventfort and the results of using the polypeptide complex in patients with cerebral vascular atherosclerosis.

Additionally, the article reviews the efficacy of other Peptides preparations, such as Adestab and Previn, and suggests schemes of their use for prevention and treatment of cardiovascular diseases.

The scientific lecture is prepared by Natalia Linkova:

• Doctor of Biological Sciences, professor
• Head of Laboratory of Molecular Mechanisms of Ageing in Saint-Petersburg Institute of bioregulation and gerontology
• Leading researcher in research laboratory of drug delivery system developing in Saint-Petersburg Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation
• Author of more than 400 scientific publications

We are confident that this information will be of use to you and your loved ones, and we are pleased to share it with you. Stay tuned for further updates on Peptides and keep your health in mind!